aibio2005 SSY Group Limited
SSY Group (2005) news
SSY Group Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 2005, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest SSY Group news
We have not published a story on SSY Group yet. When there is news, it will appear here.
Questions about SSY Group
What is the ticker symbol of SSY Group?
SSY Group Limited trades under the ticker 2005 on HKEX.
Where is SSY Group listed?
SSY Group Limited is listed on HKEX.
Which country or territory is SSY Group listed under?
Our directory records SSY Group Limited under Hong Kong.
What does SSY Group do?
Our directory classifies SSY Group Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of SSY Group?
The ISIN recorded for SSY Group Limited is KYG8406X1034.
Does aibio.space cover SSY Group?
aibio.space lists SSY Group Limited among 2,820 public biotech companies and publishes its news here as stories appear.
Which companies are similar to SSY Group?
Companies in our directory listed in the same country and business area as SSY Group: China Biotech Services Holdings, China Traditional Chinese Medicine Holdings Co., Pak Fah Yeow International, Dawnrays Pharmaceutical Holdings, Sanai Health Industry Group Company, Regencell Bioscience Holdings.
Investor discussion: SSY Group
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Financings
Share or debt issue: PROPOSALS FOR (1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) RE-ELECTION OF RETIRING DIRECTORS (3) DECLARATION OF FINAL DIVIDEND AND NOTICE OF ANNUAL GENERAL MEETING. Source
- Financings
Share or debt issue: PROPOSALS FOR (1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) RE-ELECTION OF RETIRING DIRECTORS (3) DECLARATION OF FINAL DIVIDEND AND NOTICE OF ANNUAL GENERAL MEETING. Source
Press releases
- HKEXnews
VOLUNTARY ANNOUNCEMENT - UNAUDITED OPERATING RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2026
- HKEXnews
- HKEXnews
- HKEXnews
- HKEXnews
- HKEXnews
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON OPEN MARKET PURSUANT TO RESTRICTED SHARE AWARD SCHEME
- HKEXnews
- HKEXnews
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026
- HKEXnews
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALISED MEDICINES PROCUREMENT
- HKEXnews
- HKEXnews
- HKEXnews
BUSINESS UPDATE - LETTER OF INTENT IN RELATION TO FOUR BIOSIMILAR DRUGS
- HKEXnews
BUSINESS UPDATE - LETTER OF INTENT IN RELATION TO TWO CLASS 2 MODIFIED NEW DRUGS
- HKEXnews
- HKEXnews
VOLUNTARY ANNOUNCEMENT - UNAUDITED OPERATING RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2026
- HKEXnews
- HKEXnews
- HKEXnews
- HKEXnews
- HKEXnews
Stock chart
Listing details
- Company
- SSY Group Limited
- Ticker
- 2005
- Listing
- HKEX
- Country or territory
- Hong Kong
- Business scope
- Pharmaceuticals: Major
- ISIN
- KYG8406X1034
- Last quote in directory
- 2026-10-22
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction